These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21120540)

  • 1. Complementary and alternative medicine use among newly diagnosed prostate cancer patients.
    McDermott CL; Blough DK; Fedorenko CR; Arora NK; Zeliadt SB; Fairweather ME; Oakley-Girvan I; Van Den Eeden SK; Ramsey SD
    Support Care Cancer; 2012 Jan; 20(1):65-73. PubMed ID: 21120540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.
    Ramsey SD; Zeliadt SB; Blough DK; Fedorenko CR; Fairweather ME; McDermott CL; Penson DF; Van Den Eeden SK; Hamilton AS; Arora NK
    Urology; 2012 May; 79(5):1034-41. PubMed ID: 22546381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
    Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
    Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
    Singh H; Maskarinec G; Shumay DM
    Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-physician communication regarding use of complementary therapies during cancer treatment.
    Roberts CS; Baker F; Hann D; Runfola J; Witt C; McDonald J; Livingston ML; Ruiterman J; Ampela R; Kaw OC; Blanchard C
    J Psychosoc Oncol; 2005; 23(4):35-60. PubMed ID: 16618687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
    Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
    J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on: "Satisfaction with information used to choose prostate cancer treatment." Gilbert SM, Sanda MG, Dunn RL, Greenfield TK, Hembroff L, Klein E, Saigal CS, Pisters L, Michalski J, Sandler HM, Litwin MS, Wei JT. H. Lee Moffitt Cancer Center, Tampa, Florida; Department of Urology, Emory University, Atlanta, Georgia; Department of Urology, University of Michigan, Ann Arbor, Michigan; Department of Psychiatry and Public Health Institute, University of California-San Francisco, California; Institute for Public Policy and Social Research, Michigan State University, Lansing, Michigan; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio; Department of Urology and Department of Health Policy and Management, University of California-Los Angeles, Los Angeles, California; Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.: J Urol 2014;191(5):1265-71. doi:10.1016/j.juro.2013.12.008. [Epub 2013 Dec 12].
    Brent H
    Urol Oncol; 2016 May; 34(5):247-8. PubMed ID: 25990613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and alternative medicine modality use and beliefs among African American prostate cancer survivors.
    Jones RA; Taylor AG; Bourguignon C; Steeves R; Fraser G; Lippert M; Theodorescu D; Mathews H; Kilbridge KL
    Oncol Nurs Forum; 2007 Mar; 34(2):359-64. PubMed ID: 17573300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
    Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
    JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of the use of alternative therapies by men with localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of complementary and alternative medicine by patients with localized prostate carcinoma: study at a single institute in Japan.
    Yoshimura K; Ichioka K; Terada N; Terai A; Arai Y
    Int J Clin Oncol; 2003 Feb; 8(1):26-30. PubMed ID: 12601539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation.
    Porter M; Kolva E; Ahl R; Diefenbach MA
    Complement Ther Med; 2008 Dec; 16(6):318-24. PubMed ID: 19028331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent use of complementary medicine by prostate cancer patients.
    Ponholzer A; Struhal G; Madersbacher S
    Eur Urol; 2003 Jun; 43(6):604-8. PubMed ID: 12767359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of use of complementary and alternative medicine in women with breast cancer.
    Lengacher CA; Bennett MP; Kip KE; Keller R; LaVance MS; Smith LS; Cox CE
    Oncol Nurs Forum; 2002; 29(10):1445-52. PubMed ID: 12432415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer.
    Chan JM; Elkin EP; Silva SJ; Broering JM; Latini DM; Carroll PR
    Urology; 2005 Dec; 66(6):1223-8. PubMed ID: 16360447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Men with prostate cancer: making decisions about complementary/alternative medicine.
    Boon H; Brown JB; Gavin A; Westlake K
    Med Decis Making; 2003; 23(6):471-9. PubMed ID: 14672107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer as part of the journey: the role of spirituality in the decision to decline conventional prostate cancer treatment and to use complementary and alternative medicine.
    White M; Verhoef M
    Integr Cancer Ther; 2006 Jun; 5(2):117-22. PubMed ID: 16685076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment.
    Shumay DM; Maskarinec G; Kakai H; Gotay CC;
    J Fam Pract; 2001 Dec; 50(12):1067. PubMed ID: 11742609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.
    Boon H; Westlake K; Stewart M; Gray R; Fleshner N; Gavin A; Brown JB; Goel V
    Urology; 2003 Nov; 62(5):849-53. PubMed ID: 14624907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study.
    Greenlee H; Kwan ML; Ergas IJ; Sherman KJ; Krathwohl SE; Bonnell C; Lee MM; Kushi LH
    Breast Cancer Res Treat; 2009 Oct; 117(3):653-65. PubMed ID: 19184414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.